Downregulating Cdk5 reverses hippocampal neuron ferroptosis by regulating the AMP-activated protein kinase pathway and “M1” polarized microglia
Journal of Neuropathology & Experimental Neurology · 2026
DOI: 10.1093/jnen/nlaf092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Na Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First People's Hospital of Zhenjiang, Jiangsu, China. Hauptthemen laut MEDLINE: Infarction, Middle Cerebral Artery, Microglia, Hypoxia-Ischemia, Brain, Cyclin-Dependent Kinase 5. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Scientific Research Project of Jiangsu Provincial Health Commission, Jiangsu University Medical Science and Technology Development Fund, Zhenjiang First People's Hospital Hospital-Level Scientific Research Foundation.
Abstract (Originalsprache)
Aberrant activation of microglia plays a crucial role in neuronal injury after ischemic stroke. Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine-directed kinase that plays a significant role in neuronal damage. We investigated the role of Cdk5 in microglial activation and neuronal ferroptosis in cellular and animal models of hypoxic-ischemic neuronal injury. Treatment with the Cdk5 inhibitor (S)-roscovitine (Ros) and/or an AMPK pathway activator metformin (Met) were investigated in a middle cerebral artery occlusion/reperfusion (MCAO/R) model in C57BL/6J mice. The results showed that Ros and Met improved neurological functions, brain edema, mitigated “M1” polarization of microglia, and inhibited neuronal ferroptosis. The combination of Ros and Met had additive effects on the MCAO/R mice. Ros and Met suppressed the expression of Cdk5 and inhibited NF-κB pathway activation, whereas the AMPK inhibitor Compound C (CC) reversed the neuroprotective and anti-inflammatory effects of Ros and Met. In vitro assays revealed that Ros and Met inhibited the proinflammatory reactions of BV2 microglia and the damage and ferroptosis of HT22 cells after OGD/R stimulation; these effects were also reversed by CC. These results indicate that targeting Cdk5 and AMPK mitigated microglia-mediated neuroinflammation and reduced neuronal ferroptosis in ischemic stroke models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First People's Hospital of Zhenjiang, Jiangsu, China.
- Department of Neurology, The Fourth People's Hospital of Zhenjiang, Jiangsu, China.
- Department of Oncology, The Fourth People's Hospital of Zhenjiang, Jiangsu, China.
ORCID-Profile: Na Liu
Förderung
- Scientific Research Project of Jiangsu Provincial Health Commission
- Jiangsu University Medical Science and Technology Development Fund
- Zhenjiang First People's Hospital Hospital-Level Scientific Research Foundation
- Zhenjiang First People’s Hospital Hospital-Level Scientific Research Foundation
Zitieren
APA
Liu, N., Peng, A., Peng, B., Xia, H., Zhang, Z., Zhang, D., Xu, S., & Xu, H. (2026). Downregulating Cdk5 reverses hippocampal neuron ferroptosis by regulating the AMP-activated protein kinase pathway and “M1” polarized microglia. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf092
Vancouver
Liu N, Peng A, Peng B, Xia H, Zhang Z, Zhang D, et al. Downregulating Cdk5 reverses hippocampal neuron ferroptosis by regulating the AMP-activated protein kinase pathway and “M1” polarized microglia. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlaf092
BibTeX
@article{Liu2026,
author = {Liu, Na and Peng, Aini and Peng, Bo and Xia, Haiping and Zhang, Zhenzhen and Zhang, Dandan and Xu, Shoucheng and Xu, Hang},
title = {Downregulating Cdk5 reverses hippocampal neuron ferroptosis by regulating the AMP-activated protein kinase pathway and “M1” polarized microglia},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlaf092}
}
EUVIMED